tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VNDA Stock Latest News

Vanda Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
The FlyVanda Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
15d ago
VNDA
Vanda Pharmaceuticals: Strong Financial Performance and Strategic Growth Justify Buy Rating
PremiumRatings
Vanda Pharmaceuticals: Strong Financial Performance and Strategic Growth Justify Buy Rating
15d ago
VNDA
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges
20d ago
VNDA
Vanda Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Vanda Pharmaceuticals Reports Q1 2025 Financial Results
21d ago
VNDA
Vanda Pharmaceuticals reports Q1 EPS (50c) vs. (7c) last year
PremiumThe Fly
Vanda Pharmaceuticals reports Q1 EPS (50c) vs. (7c) last year
21d ago
VNDA
Vanda Pharmaceuticals says Bysanti NDA decision expected in early 2026
PremiumThe FlyVanda Pharmaceuticals says Bysanti NDA decision expected in early 2026
24d ago
VNDA
Vanda Pharmaceuticals (VNDA) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Vanda Pharmaceuticals (VNDA) Q1 Earnings Cheat Sheet
1M ago
VNDA
Vanda says FDA ‘unlawfully’ delaying hearing
Premium
The Fly
Vanda says FDA ‘unlawfully’ delaying hearing
1M ago
VNDA
Vanda Pharmaceuticals: Strategic Advancements and Financial Strength Underpin Buy Rating
PremiumRatings
Vanda Pharmaceuticals: Strategic Advancements and Financial Strength Underpin Buy Rating
2M ago
VNDA
Vanda Pharmaceuticals submits NDA to FDA for Bysanti
PremiumThe Fly
Vanda Pharmaceuticals submits NDA to FDA for Bysanti
2M ago
VNDA
Positive Outlook for Vanda Pharmaceuticals: FDA Acceptance and Strong Financial Position Bolster Buy Rating
PremiumRatings
Positive Outlook for Vanda Pharmaceuticals: FDA Acceptance and Strong Financial Position Bolster Buy Rating
2M ago
VNDA
Vanda Pharmaceuticals’ New Drug Application Accepted by FDA
PremiumCompany Announcements
Vanda Pharmaceuticals’ New Drug Application Accepted by FDA
2M ago
8K
VNDA
Vanda Sets 2025 Executive Compensation Plans
PremiumCompany AnnouncementsVanda Sets 2025 Executive Compensation Plans
3M ago
8K
VNDA
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
Premium
Ratings
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
3M ago
VNDA
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
Premium
The Fly
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
3M ago
VNDA
Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
PremiumCompany Announcements
Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism
3M ago
VNDA
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
PremiumCompany Announcements
Vanda Pharmaceuticals Sees Revenue Growth Amid Strategic Expansions
3M ago
VNDA
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
PremiumThe Fly
Vanda Pharmaceuticals sees FY25 revenue $210M-$250M, consensus $284.9M
3M ago
VNDA
Vanda Pharmaceuticals targets total annual revenue in excess of $1B in 2030
PremiumThe Fly
Vanda Pharmaceuticals targets total annual revenue in excess of $1B in 2030
3M ago
VNDA
Vanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
PremiumThe FlyVanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
3M ago
VNDA
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
Premium
Ratings
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
4M ago
VNDA
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
Premium
The Fly
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
4M ago
ANAB
VNDA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >